Aegerion Pharma (AEGR) Tops Q3 EPS by 7c; Boosts FY13 Revs Outlook
Tweet Send to a Friend
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q3 EPS of ($0.43), $0.07 better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
